Pharmacokinetic optimisation of antibacterial treatment in patients with cystic fibrosis. Current practice and suggestions for future directions. (Q40829169)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Pharmacokinetic optimisation of antibacterial treatment in patients with cystic fibrosis. Current practice and suggestions for future directions.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884816%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

Europe PubMed Central

Pharmacokinetic optimisation of antibacterial treatment in patients with cystic fibrosis. Current practice and suggestions for future directions (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884816%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

cystic fibrosis

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

Alexander Vinks

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884816%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

D J Touw

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884816%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J W Mouton

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884816%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A M Horrevorts

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884816%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 December 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884816%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Clinical Pharmacokinetics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884816%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884816%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884816%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

437-459

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884816%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Inhalation of antibiotics in cystic fibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tobramycin Serum Concentrations After Aerosol and Oral Administration in Cystic Fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftazidime disposition in acute and stable cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibacterial therapy in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Saturation of the tubular excretion of beta-lactam antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Individualized aminoglycoside dosage regimens in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Computation of drug concentrations in endocardial vegetations in patients during antibiotic therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Macromolecular mechanisms of sputum inhibition of tobramycin activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mathematical Examination of Dual Individualization Principles (I): Relationships between AUC above MIC and Area under the Inhibitory Curve for Cefmenoxime, Ciprofloxacin, and Tobramycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased renal clearance of cefsulodin due to higher glomerular filtration rate in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tobramycin elimination rate change from first to later doses in older cystic fibrosis patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic-pharmacodynamic modeling of activity of ceftazidime during continuous and intermittent infusion.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ticarcillin/clavulanic acid pharmacokinetics in children and young adults with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absolute bioavailability and absorption characteristics of aerosolized tobramycin in adults with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic evaluation of imipenem combined with cilastatin in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lung distribution and pharmacokinetics of aerosolized tobramycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of ticarcillin in patients with cystic fibrosis: a controlled prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dosing implications of altered gentamicin disposition in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suggestions for the optimization of the initial tobramycin dose in adolescent and adult patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of azlocillin in children with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of once-daily amikacin dosing in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics of antimicrobial drugs in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Pseudomonas aeruginosa lung infection in cystic fibrosis with high or conventional doses of ceftazidime

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emergence of antibiotic resistance amongst Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Individualising gentamicin dosage regimens. A comparative review of selected models, data fitting methods and monitoring strategies

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of tobramycin monitoring in adolescent and adult patients with cystic fibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation and treatment of cystic fibrosis patients with lung infections caused by Pseudomonas (Burkholderia) cepacia and multiresistant Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized double-blind evaluation of ceftazidime dose ranging in hospitalized patients with cystic fibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cystic fibrosis: a review of pulmonary infections and interventions

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftazidime in cystic fibrosis: pharmacokinetics and therapeutic response

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic management of cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimisation of aminoglycoside toxicity in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetics of antimicrobial activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disposition of drugs in cystic fibrosis. I. Sulfamethoxazole and trimethoprim

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tobramycin in patients with cystic fibrosis. Adjustment in dosing interval for effective treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of a once-daily netilmicin regimen in the treatment of cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aminoglycoside ototoxicity in cystic fibrosis. Evaluation by high-frequency audiometry.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Creatinine clearance as predictor of tobramycin elimination in adult patients with cystic fibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gentamicin and tobramycin pharmacokinetics in patients with cystic fibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aminoglycoside induced ototoxicity in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacology of antibiotics and other drugs in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of once-daily versus thrice daily tobramycin in cystic fibrosis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cloxacillin absorption and disposition in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The tubular excretion of benzylpenicillin in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal clearance of gentamicin in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of unique ciprofloxacin pharmacokinetic characteristics in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of antimicrobial drugs in cystic fibrosis. Aminoglycoside antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of drugs in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic interaction and diffusion through alginate and exopolysaccharide of cystic fibrosis-derived Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of amikacin in cystic fibrosis: a study of bronchial diffusion.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftazidime in treatment of acute pulmonary exacerbations in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aminoglycoside-Induced Nephrotoxicity in Cystic Fibrosis: A Case Presentation and Review of the Literature.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of piperacillin, a semisynthetic penicillin, in the therapy of acute exacerbations of pulmonary disease in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of vancomycin in adult cystic fibrosis patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic activity in sputum

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Individualization of tobramycin dosage in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of ceftazidime in adult cystic fibrosis patients during continuous infusion and ambulatory treatment at home.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-dose pharmacokinetics of cefsulodin in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and serum bactericidal activity of vancomycin alone and in combination with ceftazidime in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and dosage requirements of netilmicin in cystic fibrosis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of glomerular filtration rate and effective renal plasma flow in cystic fibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of 6 and 8 hourly tobramycin dosing intervals in treatment of pulmonary exacerbations in cystic fibrosis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of tobramycin in patients with cystic fibrosis. Implications for the dosing interval.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolerance, pharmacokinetics and efficacy of once daily amikacin for treatment of Pseudomonas aeruginosa pulmonary exacerbations in cystic fibrosis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, bayesian feedback and individualised target goals

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of netilmicin in children with and without cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The diffusion of beta-lactam antibiotics through mixed gels of cystic fibrosis-derived mucin and Pseudomonas aeruginosa alginate

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of potential ototoxicity following high-dose nebulized tobramycin in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of cefepime in cystic fibrosis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and bronchial diffusion of single daily dose amikacin in cystic fibrosis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of two dosage regimens of ciprofloxacin during a two-week therapeutic trial in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and safety of tobramycin after once-daily administration in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population pharmacokinetics of ceftazidime in cystic fibrosis patients analyzed by using a nonparametric algorithm and optimal sampling strategy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of ceftazidime pharmacokinetic indices with therapeutic outcome in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Azlocillin pharmacokinetics in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective evaluation of a dose prediction algorithm for intravenous tobramycin in adolescent and adult patients with cystic fibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of a fluorescence polarographic immunoassay with increased sensitivity for measurement of low concentrations of tobramycin in serum

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum and sputum concentrations of azlocillin, cefoperazone and ceftazidime in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased dosage requirements of tobramycin and gentamicin for treating Pseudomonas pneumonia in patients with cystic fibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and sputum penetration of ciprofloxacin in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamics of ciprofloxacin in cystic fibrosis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical management of children and adults with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is continuous infusion of beta-lactam antibiotics worthwhile?--efficacy and pharmacokinetic considerations

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic modelling of intravenous tobramycin in adolescent and adult patients with cystic fibrosis using the nonparametric expectation maximization (NPEM) algorithm

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment: clinical outcome, microbiology and pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disposition of drugs in cystic fibrosis. IV. Mechanisms for enhanced renal clearance of ticarcillin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-dose pharmacokinetics of oral ciprofloxacin in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimisation of antibiotic therapy in cystic fibrosis patients. Pharmacokinetic considerations

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered disposition of fleroxacin in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics of amikacin in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic therapy for chronic infection of pseudomonas in the lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of ciprofloxacin in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of aerosolized tobramycin in adult patients with cystic fibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complex formation between basic antibiotics and deoxyribonucleic acid in human pulmonary secretions

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of tobramycin in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of ciprofloxacin in pediatric cystic fibrosis patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cefepime. Pharmacokinetics and clinical response in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Difference in renal handling of cefsulodin between patients with cystic fibrosis and normal subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum and sputum concentrations of ceftazidime in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continuous infusion of beta-lactam antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The difficulties of treating infection in adults with cystic fibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intrapatient variation in aminoglycoside disposition in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum bactericidal activity of ceftazidime: continuous infusion versus intermittent injections.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of Methicillin in Patients with Cystic Fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cefepime pharmacokinetics in cystic fibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics in the 21st century. Does the evidence support definitive outcomes?

1 reference

https://pubmed.ncbi.nlm.nih.gov/9884816

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40829169&oldid=2204019407"